COVID-19


Cards

  • Tue 03 May 2022

    Tue 03 May 2022

    Published on

    Happened on

    Omicron globally became the predominant SARS-CoV-2 variant in late 2021. Some studies have suggested Omicron has a different replication pattern that could affect detection by rapid antigen tests. Reports in social media have promulgated oral swabs as a superior sample for detecting Omicron in the early stage of infection compared to nasal swabs.

    Transitioning to Endemic COVID-19 Testing: Evidence-Based Assessment on Current and Future Rapid Antigen Test Detection

    en
    Access Now
  • Tue 03 May 2022

    Tue 03 May 2022

    Published on

    Happened on

    Faster and more effectivetechnology advances diagnostic testing within the walls of the central lab and indecentralized, near-patient settings. Explore the future of the lab and gain experts’insights on the broadened scope of the lab with test methods that provide qualityinformation supporting clinical needs and decision making.

    The lab of the future: How COVID-19 taught us the value of transcendent laboratory service

    en
    Access Now
  • Wed 30 Mar 2022

    Wed 30 Mar 2022

    Published on

    Happened on

    Join this global webinar for real-world case reports on new and breakthrough infections and practical strategies being implemented in the pediatric and adult settings that help facilitate optimal care and workflow in time sensitive care settings.

    COVID-19 co-infections: best practices for rapid differential diagnosis in pediatrics and adults

    en
    Access Now
  • Fri 11 Mar 2022

    Fri 11 Mar 2022

    Published on

    Happened on

    As variants evolve, vaccination gaps persist, and mask measures relax, diagnostic testing remains a cornerstone in the global fight against COVID-19.

    COVID-19 variants, vaccines and the value of rapid testing

    en
    Access Now
    Certified Content
  • Mon 07 Mar 2022

    Mon 07 Mar 2022

    Published on

    Happened on

    On the threshold of the 2021-2022 respiratory season, this timely update centers on influenza A&B, the COVID-19 pandemic and steps healthcare systems are taking to prepare for the upcoming (and uncertain) respiratory season

    The unpredictable respiratory season: influenza and COVID-19

    en
    Access Now
  • Published on

    This updated guidance from the Infectious Diseases Society of America (IDSA) aims to provide an evidence-based diagnostic guideline to assist clinicians, clinical laboratorians, patients and policymakers in decisions related to the optimal use of COVID-19 molecular diagnostic testing.

    IDSA guidelines on the diagnosis of COVID-19 molecular diagnostic testing

    en
    Access Now